Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05656001

Neuro- and Biofeedback in Nonsuicidal Self-injury

Nonsuicidal self-injury (NSSI) is defined as the direct, deliberate destruction of one's own body tissue without suicidal intent, typically including behaviors such as cutting, burning, or hitting oneself. The risk of engaging in NSSI is particularly high during adolescence. NSSI is associated with impairments in emotion regulation and NSSI behavior serves as an attempt to regulate emotion. We propose to examine whether training adolescents with NSSI to self-regulate using emotion regulation skills to down-regulate hemodynamic activity of the salience network, involved in emotional processing. Moreover, we propose to examine whether limbic-prefrontal cortex connectivity can be increased following neurofeedback, thereby helping adolescents find an optimal way to emotionally regulate with the help of neurofeedback, instead of engaging in NSSI to regulate emotions. We also aim to examine effects of real-time biofeedback by investigating if adolescents can regulate their psychophysiological activity during emotional reactivity with biofeedback. Sixty participants with NSSI will be recruited and offered either real-time functional magnetic resonance imaging (rt-fMRI-NF) (n = 30) or real-time biofeedback (n = 30) training. Participants each each condition will then be randomized to either an active or a control condition (n = 15/group). Participants will take part in three runs of feedback training. Changes in emotional reactivity as measured with facial electromyography (EMG) before and after feedback training will be the proximal outcome measure together with changes of the blood oxygenation level dependent (BOLD) response during real-time fMRI-neurofeedback for the neurofeedback training. Proximal outcome measures for the biofeedback will include psychophysiological measures of emotional reactivity (facialEMG). More distal outcome measures for both neuro- and biofeedback will be measures of NSSI: frequency, methods and severity as well as self-report measures of difficulties with regulating emotions, emotional reactivity and psychiatric symptoms.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Nonsuicidal Self Injury Behavior Behavioral Symptoms Emotion Regulation Emotional Regulation Self-Control Self-Injurious Behavior Social Behavior

Age range

15 year–19 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Region Östergötland

Linköping, 581 85, Sweden

Location status: Recruiting

Location contact

Anna Elander

CONTACT

[email protected]

Maria Zetterqvist, PhD

PRINCIPAL_INVESTIGATOR

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • ongoing contact at the child- and adolescent psychiatric clinics in both Linköping and Norrköping, Sweden
  • ongoing contact at the primary care facilities in Linköping and Norrköping (Ungdomshälsan, Råd, Stöd & Hälsa)
  • NSSI, independent of psychiatric diagnosis
  • between 15 and 19 years of age
  • having engaged in five or more instances of NSSI during the last six months
  • the patient is cognitively capable to decide for him- or herself

Exclusion criteria

  • anorexia in starvation with BMI 16 or under
  • substance abuse disorder
  • psychosis
  • needing interpreter
  • intellectual disability
  • and for those who do the neurofeedback, severe claustrophobia, pregnancy and braces

Treatment and study plan

Real-time functional magnetic resonance imaging Neurofeedback and Real-time Biofeedback

Other

Participants will take part in three runs of real-time functional magnetic resonance imaging feedback (rt-fMRI-NF) training with 4-8 days apart, which will be conducted at the Center for Medical Image Science and Visualization (CMIV) at the university hospital in Linköping. Participants who receive biofeedback will take part in three runs of biofeedback with 4-8 days apart conducted in the lab at the Center for Social and Affective Neuroscience (CSAN) at Linköping university. Participants will be given instructions and basic psychoeducation of brain function and the rational for down-regulating the area of the brain that drives emotion, as well as the physiological reaction that is triggered in response to emotional stimuli. The emotional stimuli are emotional pictures from the International Affective Picture System (IAPS) and the Open Affective Standardized Image Set (OASIS).

Sham functional magnetic resonance imaging neurofeedback and sham biofeedback

Other

Participants will take part in three runs of sham neurofeedback with 4-8 days apart, which will be conducted at the Center for Medical Image Science and Visualization (CMIV) at the university hospital in Linköping. Participants who receive sham biofeedback will take part in three runs of sham biofeedback with 4-8 days apart conducted in the lab at the Center for Social and Affective Neuroscience (CSAN) at Linköping university. Participants will be given instructions and basic psychoeducation of brain function and the rational for down-regulating the area of the brain that drives emotion, as well as the physiological reaction that is triggered in response to emotional stimuli. The emotional stimuli are emotional pictures from the International Affective Picture System (IAPS) and the Open Affective Standardized Image Set (OASIS).

Primary outcomes

  1. Emotional reactivity

    Time frame: Change from baseline up to 5 weeks

    Changes of emotional reactivity is measured with facial electromyography (facialEMG). High zygomatic and corrugator response indicate higher emotional reactivity.

  2. Hemodynamic activity

    Time frame: Change from baseline at up to 4 weeks

    Changes of the blood oxygenation level dependent (BOLD) response during real-time fMRI-neurofeedback for the neurofeedback training. The aim is to down-regulate the hemodynamic activity in the salience network.

  3. Psychophysiological response

    Time frame: Change from baseline at up to 4 weeks

    Changes of psychophysiological response during the real-time biofeedback training. The aim is to decrease the emotional reactivity and psychophysiological response.

Secondary outcomes

  1. Nonsuicidal self-injury

    Time frame: Change from baseline at up to 5 weeks, and at additional 6 weeks and 3 month follow-up

    Changes of self-reported frequency in nonsuicidal self-injury (NSSI). NSSI frequency is measured using the short 9-item version of the Deliberate Self-Harm Inventory (DSHI). Open ended questions are used for frequency with a range from 0 to several hundreds, depending on participants answers. Higher scores indicate more NSSI frequency and worse outcome.

  2. Difficulties with emotion regulation

    Time frame: Change from baseline at up to 5 weeks, and at additional 6 weeks and 3 month follow-up

    Changes of self-reported difficulties with emotion regulation. Difficulties with emotion regulation is measured using the 16-item version of the Difficulties with Emotion Regulation Scale (DERS-16). Scores range from 16 to 80 where higher scores indicate more difficulties with emotion regulation.

  3. Emotional reactivity

    Time frame: Change from baseline at up to 5 weeks, and at additional 6 weeks and 3 month follow-up

    Changes of self-reported emotional reactivity. Emotional reactivity is measured with the Emotion Reactivity Scale (ERS). Total scores range from 0 to 84 and a higher score indicates a worse outcome.

  4. Emotional awareness

    Time frame: Change from baseline at up to 5 weeks, and at additional 6 weeks and 3 month follow-up

    Changes of self-reported emotional awareness. Emotional awareness is measured with Toronto Alexithymia Scale, 20 items (TAS-20). TAS-20 total score ranges from 20 to 100 and higher scores indicate worse outcome.

  5. Psychiatric symptoms

    Time frame: Change from baseline at up to 5 weeks, and at additional 6 weeks and 3 month follow-up

    Changes of self-reported psychiatric symptoms. Psychiatric symptomatology is measured with the Trauma Symptom Checklist for Children (TSCC) with subscales: depression, anxiety, dissociation, posttraumatic stress, anger and sexual preoccupation. The total scale ranges from 0 to 162 and higher scores indicate worse outcome.

  6. Self-criticism

    Time frame: Change from baseline at up to 5 weeks, and at additional 6 weeks and 3 month follow-up

    Changes of self-reported levels of self-criticism. Self-criticism is measured with the Self-Rating Scale (SRS). Scores range from 8 to 56, and higher scores indicate higher levels of self-criticism.

  7. Functions of nonsuicidal self-injury

    Time frame: Change from baseline at up to 5 weeks, and at additional 6 weeks and 3 month follow-up

    Changes of self-reported levels of nonsuicidal self-injury (NSSI) functions. NSSI functions is measured using Clinical Assessment of Nonsuicidal Self-Injury Disorder Index (CANDI). Functions are rated as percentages and scores range from 0 to 100% where higher scores indicate higher usage of a specific NSSI function.

Study contacts

Contact information is provided by the study sponsor or research team.

Maria Zetterqvist, PhD

CONTACT

[email protected]

+46 10-1034339

Sponsors and collaborators

Lead sponsor

Region Östergötland

Other

Registry information

Official study title

Examining the Effects of Real-time fMRI Neurofeedback and Biofeedback in Adolescents With Nonsuicidal Self-injury

Important dates

Study start
2021
Primary completion
2027
Study completion
2027
First posted
Dec 19, 2022
Registry last updated
Sep 16, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.